Eyre; David R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Eyre; David R..The latest application filed is for "cartilage resorption assays".

Company Profile

0.15.7

Eyre; David R. - Mercer Island WA
Eyre; David R. - Seattle WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Uses of synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites Grant 6,916,604 - Eyre July 12, 2	2005-07-12
Collagen type III synthetic peptides for collagen resorption assays Grant 6,916,903 - Eyre July 12, 2	2005-07-12
Urinary assay for measuring bone resorption Grant 6,887,659 - Eyre May 3, 2	2005-05-03
Cartilage resorption assays App 20040048321 - Eyre, David R.	2004-03-11
Urinary assay for measuring bone resorption App 20040009531 - Eyre, David R.	2004-01-15
Cartilage resorption assays App 20030166032 - Eyre, David R.	2003-09-04
Uses of synthetic peptides corresponding to telopeptide sequences of cross-linked type l collagen metabolites App 20030166033 - Eyre, David R.	2003-09-04
Collagen type III synthetic peptides for collagen resorption assays Grant 6,602,980 - Eyre August 5, 2	2003-08-05
ADAMTS nucleic acids and proteins App 20030077811 - Apte, Suneel S. ; et al.	2003-04-24
Synthetic peptides for cartilage resorption assays App 20020182639 - Eyre, David R.	2002-12-05
Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum App 20010031476 - Eyre, David R.	2001-10-18
Kit for detecting analyte indicative of type II collagen resorption in vivo Grant 6,153,732 - Eyre November 28, 2	2000-11-28
Kit for detecting analyte indicative of type I collagen resorption in vivo Grant 6,027,903 - Eyre February 22, 2	2000-02-22
Methods of monitoring patient responses to anti-resorptive therapies Grant 5,939,274 - Eyre August 17, 1	1999-08-17
Methods of detecting collagen type II degradation in vivo Grant 5,919,634 - Eyre July 6, 1	1999-07-06
Detection of type 1 collagen degradation in vivo Grant 5,912,131 - Eyre June 15, 1	1999-06-15
Methods of detecting collagen type II degradation in vivo Grant 5,702,909 - Eyre December 30, 1	1997-12-30
Antibody to type-I collagen carboxy-terminal telopeptide Grant 5,656,439 - Eyre August 12, 1	1997-08-12
Method of detecting collagen degradation in vivo Grant 5,641,837 - Eyre June 24, 1	1997-06-24
Methods of detecting collagen degradation in vivo Grant 5,532,169 - Eyre July 2, 1	1996-07-02
Peptide fragments containing HP and LP cross-links Grant 5,140,103 - Eyre August 18, 1	1992-08-18
Peptide fragments containing HP and LP cross-links Grant 4,973,666 - Eyre November 27, 1	1990-11-27

Company Registrations

SEC

0001232367

EYRE DAVID R

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.